The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphoma.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Blood

• Publication date

  2006-04-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD-2005-10-4079PMID 16597597
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways.

  2005cited by this paper
• The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma.

  2003cited by this paper
• Ki‐67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma

  2002cited by this paper
• Mantle cell lymphoma

  1998cited by this paper
• Mantle cell lymphoma: a clinicopathologic study of 80 cases.

  1997cited by this paper
• Mantle-cell lymphoma: a population-based clinical study.

  1996cited by this paper
• Growth fractions in malignant non‐Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki‐67

  1984cited by this paper

• Bioactivity of Ribes nigrum L. Juice and Waste Extracts: Chemical Composition, Antioxidant, and Antiproliferative Properties

  2026cites this paper
• Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH): a randomised, open-label, phase 2/3 superiority trial

  2025cites this paper
• Diagnosis and management of mantle cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance

  2024cites this paper
• Assessment of Ki-67 Proliferative Index in Cytological Samples of Nodal B-Cell Lymphomas

  2024cites this paper
• Recent advances in genomics and therapeutics in mantle cell lymphoma.

  2023cites this paper
• A Rare Case of Nodular Mantle Cell Lymphoma of the Gastrointestinal Tract Discovered During a Routine Colonoscopy With a Positive Response to R-CHOP Chemotherapy Regimen

  2023cites this paper
• The Clinical Significance of Increased Large Cells in Marginal Zone Lymphoma.

  2023cites this paper
• Unveiling the Prognostic Significance of BCL6+/CD10+ Mantle Cell Lymphoma: Meta-Analysis of Individual Patients and Systematic Review

  2023cites this paper
• The pathological and clinical heterogeneity of mantle cell lymphoma

  2023cites this paper
• Treatment of Mantle Cell Lymphoma in the Frontline Setting: Are We Ready for a Risk-Adapted Approach?

  2022cites this paper
• Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study

  2022cites this paper
• Novel Treatments for Mantle Cell Lymphoma: From Targeted Therapies to CAR T Cells

  2021cites this paper
• The pathologic diagnosis of mantle cell lymphoma.

  2021cites this paper
• SAMHD1 Mutations and Expression in Mantle Cell Lymphoma Patients

  2021cites this paper
• Relapsed Mantle Cell Lymphoma: Current Management, Recent Progress, and Future Directions

  2021cites this paper
• Mantle cell lymphoma.

  2020cites this paper
• Injectable Porous Microchips with Oxygen Reservoirs and an Immune-Niche Enhance the Efficacy of CAR T Cell Therapy in Solid Tumors.

  2020cites this paper
• Applying Data Warehousing to a Phase III Clinical Trial From the Fondazione Italiana Linfomi Ensures Superior Data Quality and Improved Assessment of Clinical Outcomes.

  2019cites this paper
• Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in mantle cell lymphoma

  2019cites this paper
• LYMPHOPROLIFERATIVE DISORDERS

  2019cites this paper
• A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial

  2018cites this paper
• Blastic Transformation of a Mantle Cell Lymphoma Presenting as an Enlarging Unilateral Orbital Mass

  2018cites this paper
• Gastrointestinal Perforation after Rituximab Therapy in Mantle Cell Lymphoma: A Case Report

  2018cites this paper
• Prognostic value of Ki-67 index in adult medulloblastoma after accounting for molecular subgroup: a retrospective clinical and molecular analysis

  2018cites this paper
• Lymph Node Cytology

  2018cites this paper
• A British Society for haematology good practice paper on the diagnosis and investigation of patients with mantle cell lymphoma

  2018cites this paper
• The MCL35 gene expression proliferation assay predicts high‐risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapy

  2018cites this paper
• Indolente und kleinzellige B-Zell Lymphome

  2018cites this paper
• Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network

  2018cites this paper
• A Protein Intrinsic Disorder Approach for Characterising Differentially Expressed Genes in Transcriptome Data: Analysis of Cell-Adhesion Regulated Gene Expression in Lymphoma Cells

  2018cites this paper
• Design and implementation of transgenic tools to visualise cell cycle progression in mammalian development

  2017cites this paper
• Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraf fi n-Embedded Biopsies

  2017cites this paper
• LYMPHOID NEOPLASIA Telomere length in mantle cell lymphoma

  2017cites this paper
• SIRT1 activation mediates heat-induced survival of UVB damaged Keratinocytes

  2017cites this paper
• New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies.

  2017cites this paper
• Cellular Proliferation by Multiplex Immunohistochemistry Identifies High‐Risk Multiple Myeloma in Newly Diagnosed, Treatment‐Naive Patients

  2017cites this paper
• Early stages in the ontogeny of small B‐cell lymphomas: genetics and microenvironment

  2017cites this paper
• Integrative studies implicate matrix metalloproteinase‐12 as a culprit gene for large‐artery atherosclerotic stroke

  2017cites this paper
• Smoldering mantle cell lymphoma

  2017cites this paper
• Predictors of Indolent Versus Aggressive Disease Behavior for Patients With Newly Diagnosed Mantle Cell Lymphoma

  2017cites this paper
• What is the optimal initial management of the younger mantle cell lymphoma patient?

  2017cites this paper
• Leukemic non-nodal mantle cell lymphomas have a distinct phenotype and are associated with deletion of PARP1 and 13q14

  2016cites this paper
• Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.

  2016cites this paper
• Deferred therapy is associated with improved overall survival in patients with newly diagnosed mantle cell lymphoma

  2016cites this paper
• Will new drugs change the standard of care for patients with mantle cell lymphoma?

  2016cites this paper
• Mantle Cell Lymphoma.

  2016cites this paper
• Prognostic relevance of the Ki-67 proliferation index in patients with mantle cell lymphoma

  2016cites this paper
• Overexpression of heme oxygenase-1 induced by constitutively activated NF-κB as a potential therapeutic target for activated B-cell-like diffuse large B-cell lymphoma.

  2016cites this paper
• Lymphoma and Lymphoproliferative Disorders

  2015cites this paper
• Computerized image analysis of the Ki‐67 proliferation index in mantle cell lymphoma

  2015cites this paper
• Prognostic model for mantle cell lymphoma in the rituximab era: a nationwide study in Japan

  2015cites this paper
• TCL1 expression predicts overall survival in patients with mantle cell lymphoma

  2015cites this paper
• Correlation of spicule sign on computed tomography scans with peripheral lung cancers associated with interstitial lung disease and chronic obstructive pulmonary disease.

  2015cites this paper
• JARID1B deletion induced apoptosis in Jeko-1 and HL-60 cell lines.

  2015cites this paper
• Ki-67 is a strong predictor of central nervous system relapse in patients with mantle cell lymphoma (MCL).

  2015cites this paper
• Mantle cell lymphoma: evolving management strategies.

  2015cites this paper
• Role of allogeneic stem cell transplantation in mantle cell lymphoma

  2015cites this paper
• Ki-67 Labeling Indices in 'Classic' versus 'Blastoid' Mantle Cell Lymphomas--Proposed Cutoff Values for Routine Diagnostic Workup.

  2015cites this paper
• Recent advances in intestinal lymphomas

  2015cites this paper
• Ki-67 Can Predict the Response to the Gemcitabine, Oxaliplatin And L-asparaginase Regimen (GELOX) and Prognosis in Patients with Nasal Natural Killer/T-cell Lymphoma.

  2015influential citation
• No evidence of cell cycle dysregulation in mantle cell lymphoma in vivo

  2015cites this paper
• Development and characterization of a Mantle Cell Lymphoma Cell Bank in the American Type Culture Collection

  2015cites this paper
• Next-generation surveillance strategies for patients with lymphoma.

  2015cites this paper
• Complex karyotype is associated with aggressive disease and shortened progression-free survival in patients with newly diagnosed mantle cell lymphoma.

  2015cites this paper
• Mantle cell lymphoma: observation to transplantation

  2015cites this paper
• CD10-positive mantle cell lymphoma: clinicopathologic and prognostic study of 30 cases

  2015cites this paper
• Indolent mantle cell lymphoma

  2014cites this paper
• A phase I/II study of the pan Bcl-2 inhibitor obatoclax mesylate plus bortezomib for relapsed or refractory mantle cell lymphoma

  2014cites this paper
• Racial differences in mantle cell lymphoma in the United States

  2014cites this paper
• UNIVERSITY OF ZAGREB SCHOOL OF MEDICINE

  2014cites this paper
• New Paradigms in Mantle Cell Lymphoma: Is It Time to Risk-Stratify Treatment Based on the Proliferative Signature?

  2014cites this paper
• Retrospective analysis of 235 unselected patients with mantle cell lymphoma confirms prognostic relevance of Mantle Cell Lymphoma International Prognostic Index and Ki-67 in the era of rituximab: long-term data from the Czech Lymphoma Project Database

  2014cites this paper
• Is there a role for therapy response assessment with 2-[fluorine-18] fluoro-2-deoxy-d-glucose–positron emission tomography/computed tomography in mantle cell lymphoma?

  2014cites this paper
• Bortezomib for the treatment of mantle cell lymphoma

  2014cites this paper
• Treatment of mantle cell lymphomas: recommendations of the Belgian Hematological Society

  2014cites this paper
• Microvessel density of mantle cell lymphoma. A retrospective study of its prognostic role and the correlation with the Ki-67 and the mantle cell lymphoma international prognostic index in 177 cases

  2014cites this paper
• Management of relapsed/refractory mantle cell lymphoma: a review of current therapeutic strategies

  2014cites this paper
• Principles of the Pathology and Biology of Malignant Lymphomas

  2014cites this paper
• Risk factors for etiology and prognosis of mantle cell lymphoma

  2014cites this paper
• Radial-Based Signal-Processing Combined with Methods of Machine Learning

  2013cites this paper
• Heat stress: a risk factor for skin carcinogenesis.

  2013cites this paper
• Limited-stage mantle cell lymphoma: treatment outcomes at the Princess Margaret Hospital

  2013cites this paper
• Telomere length in mantle cell lymphoma.

  2013cites this paper
• Investigating the role of Class Ia phosphoinositide-3 kinase isoforms in Mantle Cell Lymphoma.

  2013cites this paper
• patients chronic lymphoproliferative disorders: analysis of a series of 432 maturation stage, and underlying cytogenetic abnormalities in B-cell Association between the proliferative rate of neoplastic B cells, their

  2013cites this paper
• Lymphoma Group rescue: a nonrandomized phase 2 multicenter study by the Nordic purged stem cell - intensive front-line immunochemotherapy with in vivo Long-term progression-free survival of mantle cell lymphoma after

  2013cites this paper
• Immunophénotypage lymphocytaire dans les syndromes lymphoprolifératifs chroniques

  2013cites this paper
• Variability in morphology and cell proliferation in sequential biopsies of mantle cell lymphoma at diagnosis and relapse: clinical correlation and insights into disease progression

  2013cites this paper
• Prognostic Factors in B-Cell Lymphomas

  2013cites this paper
• Mantle cell lymphoma: continuously improving the odds!

  2013cites this paper
• Targeting the anti-inflammatory interplay promoting glioblastoma progression with combined natural killer cells and mab9.2.27 against NG2/CSPG4. A novel strategy to reveal glioblastoma to the immune system

  2013cites this paper
• CD5-negative mantle cell lymphoma resembling extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue : a case report.

  2012cites this paper
• Increased tumor cell proliferation in mantle cell lymphoma is associated with elevated insulin-like growth factor 2 mRNA-binding protein 3 expression

  2012cites this paper
• Correlation of IDH1 Mutation with Clinicopathologic Factors and Prognosis in Primary Glioblastoma: A Report of 118 Patients from China

  2012cites this paper
• Selective CDK 4 / 6 inhibition with tumor responses by PD 0332991 in patients with mantle cell lymphoma *

  2012cites this paper
• Prognostic and predictive markers in hematologic neoplasms. A review.

  2012cites this paper
• Comparative outcome of initial therapy for younger patients with mantle cell lymphoma: an analysis from the NCCN NHL Database.

  2012cites this paper
• Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma.

  2012cites this paper
• Mantle Cell Lymphoma: Decision Making for Transplant

  2012cites this paper
• Nordic MCL2 trial update: six‐year follow‐up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem‐cell support: still very long survival but late relapses do occur

  2012cites this paper